Phase 1Active, not recruitingStart: 12 Aug 2026
First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults
Healthy Volunteers
Anaheim, United States
SponsorOtsuka Pharmaceutical Factory, Inc.
1reported site
Clinical Trials Live
Discover clinical trials around the world.
Explore public ClinicalTrials.gov records by country, condition, phase and recruitment status. Find a study, review its eligibility criteria, and connect with the listed research team.
- recruiting worldwide
- 64,821
- recruiting or opening soon worldwide
- 94,766
- recruiting with a site in India
- 608
Registry counts refresh hourly when this page is visited.
12 of 66,009 studies worldwide
Public records · ClinicalTrials.gov · recently updated first
Phase 1 / Phase 2RecruitingStart: 16 May 2023
000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Brain Tumor · Cancer
Bethesda, United States
SponsorNational Cancer Institute (NCI)
1reported site
Phase 1 / Phase 2RecruitingStart: 28 Sep 2026
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
Tuberculosis
Gaborone, Botswana; Molepolole, Botswana; Port-au-Prince, Haiti +7 more
SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
11reported sites
Phase 1 / Phase 2RecruitingStart: 22 Oct 2026
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Myelodysplastic Syndromes
Bethesda, United States
SponsorNational Cancer Institute (NCI)
1reported site
Phase 1 / Phase 2RecruitingStart: 18 Jan 2024
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Non-Small Cell Lung Cancer, NSCLC · KRAS, NRAS, HRAS-mutated NSCLC · KRAS G12C-mutated Solid Tumors, Lung Cancer · Lung Cancer Stage IV, Advanced Solid Tumor, Cancer · RAS G12D-mutated NSCLC
Gilbert, United States; Duarte, United States; Irvine, United States +78 more
SponsorRevolution Medicines, Inc.
98reported sites
Phase 1RecruitingStart: 22 Oct 2026
Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies
Lung Transplantation
Stanford, United States; Baltimore, United States; Salt Lake City, United States +1 more
SponsorNational Heart, Lung, and Blood Institute (NHLBI)
4reported sites
Phase 1RecruitingStart: 25 Sep 2025
MethaLoad Dose-Finding Study
Opioid Use Disorder (OUD)
Philadelphia, United States
SponsorAshish P Thakrar, MD MS
1reported site
Phase 1RecruitingStart: Oct 2026
Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma
HNSCC,Larynx, Pharynx and Oral Cavity · Squamous Cell Carcinoma · Head and Neck Cancer · Head and Neck Surgery
Nashville, United States
SponsorVanderbilt-Ingram Cancer Center
1reported site
Phase 1 / Phase 2Active, not recruitingStart: 29 Jun 2018
Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer
Breast Neoplasms
Seoul, South Korea
SponsorSeoul National University Hospital
1reported site
Phase 1 / Phase 2RecruitingStart: 16 Jun 2025
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
Primary Hyperoxaluria Type 1 (PH1)
Rochester, United States; Saint Paul, United States; Lyon, France +4 more
SponsorArbor Biotechnologies
7reported sites
Phase 1 / Phase 2CompletedStart: 5 Sep 2023
Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
Glioblastoma
Barcelona, Spain; Madrid, Spain
SponsorCantex Pharmaceuticals
4reported sites
Phase 1Not yet recruitingStart: Oct 2026
Effects of Trigonelline Monohydrate on NAD+ Metabolism, Pharmacokinetics, Safety, and Tolerability in Healthy Adults
NAD+ Metabolism · Pharmacokinetics · Bioavailability · Healthy Adults
Guelph, Canada
Sponsordsm-firmenich Switzerland AG
1reported site
This catalogue includes records registered on ClinicalTrials.gov, including studies outside India. It does not include every study in every national registry. PharmaBharat does not run studies, assess eligibility or enrol participants.